---
title: "Daily Debrief: What Happened Today (Oct 14)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301826992.md"
description: "Anthropic signed a government pact in Singapore for AI safety. DBS downgraded SGX to 'hold' with a S$20 target price. Singapore is building a digital bunkering data ecosystem. MAS expects firm economic growth but moderating AI activity by late 2027, while holding monetary policy steady. Meanwhile, biotech startup Nanyang Biologics prepares for a Nasdaq listing via SPAC merger."
datetime: "2026-10-14T10:23:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301826992.md)
  - [en](https://longbridge.com/en/news/301826992.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301826992.md)
generator: "portal-rs"
---

# Daily Debrief: What Happened Today (Oct 14)

Stories you might have missed

**Anthropic works to bring frontier AI models ‘on soil’ in Singapore, signs government pact**

\[SINGAPORE\] Anthropic is working to bring its most advanced artificial intelligence models “on soil” in Singapore, as the US AI company deepens its presence in the Republic through a new agreement with the government on AI safety and adoption.

* * *

**DBS downgrades SGX to ‘hold’, lowers target price to S$20**

\[SINGAPORE\] DBS Group Research has downgraded SGX to “hold” from “buy” and lowered its 12-month target price to S$20 from S$26.40.

* * *

**Singapore to build digital bunkering data ecosystem**

\[SINGAPORE\] Singapore will build a digital data ecosystem that captures bunkering data at source and automates the flow of this data with end-to-end security as it is transmitted to various parties in the value chain.

* * *

**Singapore growth to stay firm, but AI boost to moderate in 2027: MAS**

\[SINGAPORE\] The Republic’s economy is expected to continue expanding in the quarters ahead, though the pace of artificial intelligence-related activity is projected to moderate in the latter half of 2027.

* * *

**MAS holds monetary policy settings, pausing after two straight tightenings**

SINGAPORE\] The Monetary Authority of Singapore (MAS) kept monetary policy settings unchanged on Wednesday (Oct 14), pausing after two consecutive tightenings this year.

* * *

**Nasdaq listing awaits Singapore’s US$1.5 billion AI drug-discovery biotech Nanyang Biologics**

\[SINGAPORE\] Singapore-based biotech startup Nanyang Biologics (NYB) is preparing to make its Nasdaq debut through a special purpose acquisition company merger.

### Related Stocks

- [D05.SG](https://longbridge.com/en/quote/D05.SG.md)
- [S68.SG](https://longbridge.com/en/quote/S68.SG.md)

## Related News & Research

- [Singapore to streamline IPO review process from January 2027](https://longbridge.com/en/news/304243852.md)
- [Singapore speeds up IPO process with listing review functions consolidated under SGX RegCo](https://longbridge.com/en/news/304088950.md)
- [DBS Expects Mid-Single-Digit Total Income Growth in 2027](https://longbridge.com/en/news/304353753.md)
- [Singapore is fixing its market. Companies still have to fix their story](https://longbridge.com/en/news/304179482.md)
- [3 Exchange Stocks Linked To Rising AI Trading And Data Demand](https://longbridge.com/en/news/302015065.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**